BIANCA-SC: A Study of the Efficacy, Safety, and Tolerability of Blisibimod in Addition to Methotrexate During Induction of Remission in Subjects With ANCA-Associated Small Vessel Vasculitis

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 31, 2014

Primary Completion Date

June 30, 2015

Conditions
Granulomatosis With PolyangiitisMicroscopic Polyangiitis
Interventions
DRUG

Blisibimod

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Anthera Pharmaceuticals

INDUSTRY